Plain-English translation of NCT07886138 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
China
Phase
Safety & dosing
Sponsor
Xiangya Hospital of Central South University
Enrollment target
~50 participants
Started
April 2026
Primary completion
April 2027
Age range
45 Years – 80 Years
Sex
Male only
Last updated on clinicaltrials.gov in October 2026.